The more recent DNA sequencing efforts of tumors in patients without FA further underscore the importance of the FA pathway during tumor suppression and chemotherapy response, as somatic FANC gene mutations are commonly detected in diverse cancers, providing promise for tailored therapy targeting strategies3,12. The gene discussed is FANCA; the disease is cancer.